Table 1.

Assessments by time point

	Screen	Baseline 1	Baseline 2	Each session	12 weeks/end-of-treatment	6, 9, 12 months	18, 24, 30, and 36 months
Screening fully
Medical diagnosis, current smoking, and other inclusion/exclusion criteria	X
Cognitive functioning (MMSE [43])	X
Participant characteristics
Demographics (age, race, etc.)		X
Medical and smoking history		X
Nicotine dependence (FTND [50])		X
Motivation to quit (contemplation ladder [51])		X	X
MN withdrawal scale [52]			X
Primary outcomes
Current smoking/smoking since last contact		X	X	X	X	X	X
Use of other tobacco products		X	X	X	X	X	X
Saliva sample for cotinine testing			X		X	X
Exhaled breath sample for CO testing			X		X	X
Depressive symptoms (PHQ-9 [53])		X	X		X	X	X
Depressive symptoms (CESD-10 [66])		X	X		X	X
Secondary outcomes
Positive and negative affect (PANAS [57])		X	X		X	X	X
Reactive anhedonia (SHAPS [68, 69])		X	X		X	X
Perceived stress scale (PSS-4 [70])		X			X	X
Health related quality of life (SF-12 [71])		X			X	X
Exercise tolerance (DASI [72])		X			X	X
MACE/mortality					X	X	X
Adverse event monitoring			X	X	X	X	X
Hypothesized BA mediators
Pleasant/valued activities (BADS [76], PES [79, 80])		X			X	X
Acceptability
Treatment acceptability (CSQ-8 [81])					X
Potential confounders
Medication adherence questions [88, 89]		X			X	X
Diet/exercise questions [92]		X			X	X
Counseling sessions attended				X
Cardiac rehabilitation attendance					X	X
Outside of study depression treatment					X	X
Outside of study smoking cessation treatment					X	X